FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used for screening of probability of presence of bladder cancer (BC) in patients of Caucasian race. Level of biomarkers in a biological fluid sample obtained in a subject is measured: sVCAM.1, ApoA1, CA19.9, ApoA2, CYFRA.21.1, Ddimer, ApoB, hsCRP, TTR, B2M. Patient's sex is determined. Set of obtained values of biomarkers is processed with using at least one classification model trained to determine high or low probability of bladder cancer.
EFFECT: method provides higher accuracy of screening detection of cancer in the patients of the Caucasian race by using a classification model trained to determine a high or low probability of the presence of the bladder cancer.
4 cl, 9 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SCREENING PROBABILITY OF BREAST CANCER PRESENCE | 2019 |
|
RU2718272C1 |
| METHOD FOR EARLY DIAGNOSIS OF LUNG CANCER | 2018 |
|
RU2697971C1 |
| SYSTEM AND METHOD FOR SCREENING THE PROBABILITY OF HAVING COLORECTAL CANCER | 2018 |
|
RU2698854C1 |
| METHOD FOR SCREENING PROBABILITY OF KIDNEY CANCER | 2023 |
|
RU2816798C1 |
| METHOD FOR DIAGNOSTICS OF LUNG CANCER | 2021 |
|
RU2784356C1 |
| METHOD OF APPLYING INFORMATION ON A COMPLEX GROUP OF BIOMARKERS FOR DIAGNOSING A MALIGNANT LUNG TUMOR IN SUBJECT, DIAGNOSTIC KIT AND COMPUTER SYSTEM USING IT | 2017 |
|
RU2687578C2 |
| METHOD OF NON-INVASIVE DIAGNOSIS OF BLADDER CANCER BASED ON DETECTION OF TUMOR DNA IN BIOLOGICAL FLUIDS AND SET OF REAGENTS FOR ITS IMPLEMENTATION | 2023 |
|
RU2813669C1 |
| METHOD FOR PREDICTION OF THE PROBABILITY OF INTRAOPERATIVE AND EARLY POSTOPERATIVE COMPLICATIONS IN ORGAN-PRESERVING OPERATIONS IN RENAL PARENCHYMAL TUMORS | 2019 |
|
RU2709837C1 |
| METHOD OF ASSESSING THE RISK OF THYROID CANCER IN PATIENTS WITH NODULAR GOITER SYNDROME | 2023 |
|
RU2814933C1 |
| METHOD OF DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION | 2023 |
|
RU2814392C1 |
